...
Continue reading >>The stock market closed mostly higher on Monday and the first official trading day for May despite mixed economic news as first-quarter earnings remain broadly supportive. Specifically, news that 87% of the S&P 500 companies that had reported through last Friday have topped analysts' expectations helped bullish sentiment. The Dow traded to a midday high of 34,221 while ending at 34,113...
Continue reading >>Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100% success against severe cases of the disease. COVAXIN...
Continue reading >>The stock market closed mostly higher on Monday and the first official trading day for May despite mixed economic news as first-quarter earnings remain broadly supportive. Specifically, news that 87% of the S&P 500 companies that had reported through last Friday have topped analysts' expectations helped bullish sentiment.The Dow traded to a midday high of 34,221 while ending at 34,113...
Continue reading >>...
Continue reading >>The stock market struggled on Friday and the last trading day of April as profit taking going into the weekend and month end weighed on sentiment. However, the four major indexes posted strong gains for the month with the S&P 500 leading the way after jumping 5.2% while the Nasdaq rose 5%. The Dow was up 2.5% and the Russell 2000 added 2.1% in April. Despite the good news, one concern...
Continue reading >>